Magellan Health (MGLN) Misses Q1 EPS by 20c

April 26, 2018 6:44 AM EDT

Magellan Health (NASDAQ: MGLN) reported Q1 EPS of $0.81, $0.20 worse than the analyst estimate of $1.01. Revenue for the quarter came in at $1.81 billion versus the consensus estimate of $1.83 billion.

GUIDANCE:

Magellan Health sees FY2018 EPS of $5.90-$6.68, versus the consensus of $6.71.

For earnings history and earnings-related data on Magellan Health (MGLN) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance

Related Entities

Earnings